Cost of Care

DOJ’s $541.5M–$542M settlement with Humana-owned The Villages Health over alleged Medicare Advantage diagnosis-code manipulation intensifies scrutiny on MA risk adjustment and raises immediate compliance risk for capitated provider groups, payers, and ACO-like entities relying on coding-driven revenue under value-based contracts (Healthcare Dive). At the same time, Medicaid hospital economics are tightening as OBBBA limits on state-directed payments could reduce funding across 37 states, while commercial and provider-led VBC activity continues to move into specialty episodes, including BCBSM’s MSK condition-based model and Transcarent’s bundled payments for CAR T/BiTE therapies—signaling growing pressure to prove cost control beyond primary care (HFMA).